The X‑ray tubes for CT market is primarily segmented by application, a categorization that dictates demand distribution and revenue contribution. Diagnostic imaging—covering routine body‑scan, cardiac and oncology examinations—commands the bulk of the market, representing roughly 70 % of total sales due to universal hospital adoption and high replacement cycles. Interventional CT, employed in image‑guided biopsies, vascular embolization and minimally invasive surgeries, accounts for about 20 % of the market; its higher unit price and growing procedural volume elevate its share. Research and development applications, including prototype scanners and pre‑clinical studies, occupy the remaining 10 %, characterized by low unit counts but premium pricing for specialized tube designs. Regional data reveal North America and Europe dominate the diagnostic segment, while Asia‑Pacific shows the fastest CAGR, driven by expanding imaging infrastructure. Collectively, these application categories form the core of the market taxonomy and directly shape production scaling, supply‑chain logistics and pricing strategies within the overall X‑ray tubes for CT segmentation.